{"id":43397,"date":"2025-10-15T12:54:43","date_gmt":"2025-10-15T04:54:43","guid":{"rendered":"https:\/\/flcube.com\/?p=43397"},"modified":"2025-10-15T12:54:44","modified_gmt":"2025-10-15T04:54:44","slug":"national-joint-procurement-office-announces-11th-round-vbp-astrazeneca-dapagliflozin-leads-demand","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=43397","title":{"rendered":"National Joint Procurement Office Announces 11th Round VBP, AstraZeneca\u202fDapagliflozin Leads Demand"},"content":{"rendered":"\n<p>On October\u202f11, 2025, the National Joint Procurement Office (NJPO) released the full company list for the 11th round of the National Organized Centralized Drug Procurement (VBP). The announcement confirmed that <strong>396 companies<\/strong> successfully passed the information review and are now eligible to compete for the government\u2011designated volumes.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-key-highlights\">Key Highlights<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Total Specified Demand<\/strong><\/td><td>~3.7\u202fbillion doses (\u2248\u202f75\u202f% of the previously disclosed total volume)<\/td><\/tr><tr><td><strong>Top\u2011Demand Drug<\/strong><\/td><td><strong>AstraZeneca\u2019s Dapagliflozin<\/strong> \u2013 &gt;\u202f460\u202fmillion tablets<\/td><\/tr><tr><td><strong>Most Competitive Category<\/strong><\/td><td>Diprophylline Injection \u2013 48 companies bidding<\/td><\/tr><tr><td><strong>Largest Multi\u2011Product Participant<\/strong><\/td><td><strong>Better Pharmaceutical<\/strong> \u2013 17 product entries<\/td><\/tr><tr><td><strong>New Entrants<\/strong><\/td><td>19 firms newly added to the competition<\/td><\/tr><tr><td><strong>Unique Allocation<\/strong><\/td><td>Ningxia Zhouyang Pharmaceutical received 1.5\u202fmillion doses of Adenosylcobalamin; 18 companies remain unassigned<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-impact-of-brand-independent-selection\">Impact of Brand\u2011Independent Selection<\/h2>\n\n\n\n<p>The NJPO\u2019s option for medical institutions to choose brands independently has <strong>boosted participation from foreign origin\u2011research companies<\/strong>. Big names such as <strong>AstraZeneca, Roche, Chugai Pharmaceutical, and Novartis<\/strong> now compete in the centralized procurement pool, adding depth and choice to the national supply chain.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-what-this-means-for-the-market\">What This Means for the Market<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Supply Chain Resilience<\/strong> \u2013 Near\u2011triple\u2011digit demand for Dapagliflozin signals robust market uptake for type\u20112\u2011diabetes therapeutics.<\/li>\n\n\n\n<li><strong>Competitive Pricing<\/strong> \u2013 The influx of 396 vendors is expected to drive price reductions and improve access across the country.<\/li>\n\n\n\n<li><strong>Innovation Incentive<\/strong> \u2013 The inclusion of foreign origin\u2011research firms encourages technology transfer and local capacity building.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-about-the-national-joint-procurement-office\">About the National Joint Procurement Office<\/h2>\n\n\n\n<p>The NJPO is the central agency responsible for coordinating nationwide drug procurement, ensuring the efficient allocation of critical medicines and fostering transparency in the pharmaceutical market.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>On October\u202f11, 2025, the National Joint Procurement Office (NJPO) released the full company list for&#8230;<\/p>\n","protected":false},"author":1,"featured_media":43400,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[82],"class_list":["post-43397","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory","tag-vbp-voluem-based-procurement"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>National Joint Procurement Office Announces 11th Round VBP, AstraZeneca\u202fDapagliflozin Leads Demand - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"On October\u202f11, 2025, the National Joint Procurement Office (NJPO) released the full company list for the 11th round of the National Organized Centralized Drug Procurement (VBP). The announcement confirmed that 396 companies successfully passed the information review and are now eligible to compete for the government\u2011designated volumes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=43397\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"National Joint Procurement Office Announces 11th Round VBP, AstraZeneca\u202fDapagliflozin Leads Demand\" \/>\n<meta property=\"og:description\" content=\"On October\u202f11, 2025, the National Joint Procurement Office (NJPO) released the full company list for the 11th round of the National Organized Centralized Drug Procurement (VBP). The announcement confirmed that 396 companies successfully passed the information review and are now eligible to compete for the government\u2011designated volumes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=43397\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-15T04:54:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-15T04:54:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1504.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43397#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43397\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"National Joint Procurement Office Announces 11th Round VBP, AstraZeneca\u202fDapagliflozin Leads Demand\",\"datePublished\":\"2025-10-15T04:54:43+00:00\",\"dateModified\":\"2025-10-15T04:54:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43397\"},\"wordCount\":261,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43397#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1504.webp\",\"keywords\":[\"VBP (voluem-based procurement)\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43397#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43397\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=43397\",\"name\":\"National Joint Procurement Office Announces 11th Round VBP, AstraZeneca\u202fDapagliflozin Leads Demand - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43397#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43397#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1504.webp\",\"datePublished\":\"2025-10-15T04:54:43+00:00\",\"dateModified\":\"2025-10-15T04:54:44+00:00\",\"description\":\"On October\u202f11, 2025, the National Joint Procurement Office (NJPO) released the full company list for the 11th round of the National Organized Centralized Drug Procurement (VBP). The announcement confirmed that 396 companies successfully passed the information review and are now eligible to compete for the government\u2011designated volumes.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43397#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43397\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43397#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1504.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1504.webp\",\"width\":1080,\"height\":608,\"caption\":\"National Joint Procurement Office Announces 11th Centralized Drug Procurement Round, AstraZeneca\u202fDapagliflozin Leads Demand\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43397#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"National Joint Procurement Office Announces 11th Round VBP, AstraZeneca\u202fDapagliflozin Leads Demand\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"National Joint Procurement Office Announces 11th Round VBP, AstraZeneca\u202fDapagliflozin Leads Demand - Insight, China&#039;s Pharmaceutical Industry","description":"On October\u202f11, 2025, the National Joint Procurement Office (NJPO) released the full company list for the 11th round of the National Organized Centralized Drug Procurement (VBP). The announcement confirmed that 396 companies successfully passed the information review and are now eligible to compete for the government\u2011designated volumes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=43397","og_locale":"en_US","og_type":"article","og_title":"National Joint Procurement Office Announces 11th Round VBP, AstraZeneca\u202fDapagliflozin Leads Demand","og_description":"On October\u202f11, 2025, the National Joint Procurement Office (NJPO) released the full company list for the 11th round of the National Organized Centralized Drug Procurement (VBP). The announcement confirmed that 396 companies successfully passed the information review and are now eligible to compete for the government\u2011designated volumes.","og_url":"https:\/\/flcube.com\/?p=43397","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-15T04:54:43+00:00","article_modified_time":"2025-10-15T04:54:44+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1504.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=43397#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=43397"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"National Joint Procurement Office Announces 11th Round VBP, AstraZeneca\u202fDapagliflozin Leads Demand","datePublished":"2025-10-15T04:54:43+00:00","dateModified":"2025-10-15T04:54:44+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=43397"},"wordCount":261,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=43397#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1504.webp","keywords":["VBP (voluem-based procurement)"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=43397#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=43397","url":"https:\/\/flcube.com\/?p=43397","name":"National Joint Procurement Office Announces 11th Round VBP, AstraZeneca\u202fDapagliflozin Leads Demand - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=43397#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=43397#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1504.webp","datePublished":"2025-10-15T04:54:43+00:00","dateModified":"2025-10-15T04:54:44+00:00","description":"On October\u202f11, 2025, the National Joint Procurement Office (NJPO) released the full company list for the 11th round of the National Organized Centralized Drug Procurement (VBP). The announcement confirmed that 396 companies successfully passed the information review and are now eligible to compete for the government\u2011designated volumes.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=43397#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=43397"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=43397#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1504.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1504.webp","width":1080,"height":608,"caption":"National Joint Procurement Office Announces 11th Centralized Drug Procurement Round, AstraZeneca\u202fDapagliflozin Leads Demand"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=43397#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"National Joint Procurement Office Announces 11th Round VBP, AstraZeneca\u202fDapagliflozin Leads Demand"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1504.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=43397"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43397\/revisions"}],"predecessor-version":[{"id":43401,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43397\/revisions\/43401"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/43400"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=43397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=43397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=43397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}